DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fury MG, Sherman EJ, Rao SS. et al.
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Ann Oncol 2014;
25 (03) 689-694
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.